Protective effect of l-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Uzunoglu, Sernaz ^a   Karagol, Hakan ^a   Ozpuyan, Fulya ^a   Cosar, Rusen ^a   Cicin, Irfan ^a   Yurutcaloglu, Vuslat ^a   Denizli, Bengü ^a   Tanriverdi, Özgür ^b   Sut, Necdet ^a   Kocak, Zafer ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Amifostine; Carnitine; Cisplatin; Drug toxicity

Indexed keywords

AMIFOSTINE; CARNITINE; CISPLATIN; CREATININE; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

EID: 84655170130     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9746-2     Document Type: Article

References (34)

1. T Boulikas M Vougiouka 2003 Cisplatin and platinum drugs at the molecular level Oncol Rep 10 1663 1682
2. DM Townsend M Deng L Zuong MG Lapus MH Harigan 2003 Metabolism of cisplatin to a nephrotoxin in proximal tubule cells J Am Soc Nephrol 14 1 10 (Pubitemid 36026291)
3. AC Seguro MH Shimizu LH Kudo A dos Santos Rocha 1989 Renal concentration defect induced by cisplatin. The role of thick ascending limb and papillary collecting duct Am J Nephrol 9 59 65 (Pubitemid 19102720)
4. F TokatlI 2004 The potential cardioprotective effects of amifostine in irradiated rats Int J Radiant Oncol Biol Phys 58 1228 1234 (Pubitemid 38314808)
5. C Uzal 2004 The protective effect of amifostine on radiation-induced acute pulmonary toxicity: detection by 99-m Tc-DTPA transalveolar clearances Int J Radiant Oncol Biol Phys 60 564 569 (Pubitemid 39233478)
6. M Treskes WJ Van der Vijgh 1993 WR-2721 as a modulator of cisplatin and carboplatin- induced side effects in comparison with other chemoprotective agents: a molecular approach. Cancer Chemother Pharmacol 33 93 106 (Pubitemid 23325409)
7. M Treskes LG Nijtmans AM Fichtinger-Chapmen WJ Van der Vijgh 1992 Effects of the modulating agent WR 2721 and its main metabolites on the formation and stability of cisplatin DNA adducts in vitro in comparison to the effect of thiosulfate and diethhylthiocarbamate Biochem Parmacol 43 1013 1019
8. LM Schuchter J Glick 1993 The current status of WR-2721 (amifostine): a chemotherapy and radiation therapy protector Biol Ther Cancer 3 1 10
9. ML Hensley 2009 American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants J Clin Oncol 27 127 145
10. A Vanella 2000 l-Propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector Cell Biol Toxicol 16 99 104 (Pubitemid 30451545)
11. B Chang M Nishikavva E Sato K Utsumi M Inoue 2002 l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine Arch Biochem Biophys 405 55 64 (Pubitemid 35026166)
12. JD Kopple 2002 l-Carnitine ameliorates gentamicin-induced renal injury in rats Nephrol Dial Transplant 17 2122 2131 (Pubitemid 35446667)
13. D Boonsanit S Kanchanapangka C Buranakarl 2006 L Carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats Nephrology 11 313 320 (Pubitemid 44086876)
14. G Sener 2004 l-Carnitine ameliorates oxidative damage due to chronic renal failure in rats J Cardiovasc Pharmacol 43 698 705 (Pubitemid 38534071)
15. M Caloglu 2009 Histopathological and scintigraphic comparisons of the protective effects of l-carnitine and amifostine against radiation-induced late renal toxicity in rats Clin Exp Pharmacol Physiol 36 523 530
16. CIOMS International Guiding Principles for Biomedical Research Involving Animals. Altern Lab Anim. 1985; 12:ii.
17. I Arany RL Safirstein 2003 Cisplatin nephrotoxicity Semin Nephrol 23 460 464 (Pubitemid 37176691)
18. BH Ali MS Al-Moundhri 2006 Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research Food Chem Toxicol 44 1173 1183
19. CM Spencer KL Goa 1995 Amifostine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector Drugs 50 1001 1031
20. V Santini FJ Giles 1999 The potential of amifostine: from cytoprotectant to therapeutic agent Haematologica 84 1035 1042
21. V Santini 2001 Amifostine: chemotherapeutic and radiotherapeutic protective effects Exp Opin Pharmocother 2 479 489 (Pubitemid 32427744)
22. JA Foster-Nora R Siden 1997 Amifostine for protection from antineoplastic drug toxicity Am J Health Syst Pharm 54 787 800 (Pubitemid 27174802)
23. M Calvani 2004 Carnitine replacement in end-stage renal disease and hemodialysis Ann N Y Acad Sci 1033 52 66 (Pubitemid 39656738)
24. C Pisano 2003 Paclitaxel and cisplatin- induced neurotoxicity. A protective role of acetyl-l-Carnitine Clin Cancer Res 9 5756 5767 (Pubitemid 37499500)
25. N Aydogdu 2006 Protective effects of l-Carnitine on myoglobinuric acute renal failure in rats Clin Exp Pharmacol Physiol 33 119 124
26. AM Aleisa 2007 Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-l-Carnitine in rat kidney tissues Clin Exp Pharmacol Physiol 34 1252 1259 (Pubitemid 350013238)
27. RC Srivastava 1996 Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats Biometals 9 139 142 (Pubitemid 26144593)
28. MM Sayad-Ahmed 2004 Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model Chemotherapy 50 162 170
29. JM Ward KA Fauvie 1976 The nephrotoxic effect of cis-dichlorodiamine- platinum in male F344 rats Toxicol Appl Pharmacol 38 535 547 (Pubitemid 8010948)
30. Y Shimeda 2005 Protective effects of capsaicin against cisplatin nephrotoxicity in rats Biol Pharm Bull 28 1635 1638 (Pubitemid 41324123)
31. G Karimi M Ramezani Z Tahoonian 2005 Cisplatin nephrotoxicity and protection by milk thistle extract in rats Evid Based Complement Alternat Med 2 383 386 (Pubitemid 41253351)
32. TD Dickey J Wu LL Muldoon EA Neuwelt 2005 Protection against cisplatin-induced toxicities by N-Acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular and in vivo levels J Pharmacol Exp Ther 314 1052 1058 (Pubitemid 41205968)
33. AS Petrilli 2002 Use of amifostine in the therapy of osteosarcoma in children and adolescents J Pediatr Hematol Oncol 24 188 191 (Pubitemid 34297561)
34. J Sastry SJ Kellie 2005 Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine Pediatr Hematol Oncol 22 441 445 (Pubitemid 40993608)